JNU-HKUST Joint Laboratory for Neuroscience and Innovative Drug Research, College of Pharmacy, Jinan University, Guangzhou 510632, China.
Cells. 2020 Mar 31;9(4):835. doi: 10.3390/cells9040835.
The Rho family GTPases are small G proteins that act as molecular switches shuttling between active and inactive forms. Rho GTPases are regulated by two classes of regulatory proteins, guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). Rho GTPases transduce the upstream signals to downstream effectors, thus regulating diverse cellular processes, such as growth, migration, adhesion, and differentiation. In particular, Rho GTPases play essential roles in regulating neuronal morphology and function. Recent evidence suggests that dysfunction of Rho GTPase signaling contributes substantially to the pathogenesis of autism spectrum disorder (ASD). It has been found that 20 genes encoding Rho GTPase regulators and effectors are listed as ASD risk genes by Simons foundation autism research initiative (SFARI). This review summarizes the clinical evidence, protein structure, and protein expression pattern of these 20 genes. Moreover, ASD-related behavioral phenotypes in animal models of these genes are reviewed, and the therapeutic approaches that show successful treatment effects in these animal models are discussed.
Rho 家族 GTP 酶是小分子 G 蛋白,作为分子开关在活性和非活性形式之间转换。Rho GTP 酶受两类调节蛋白调控,即鸟嘌呤核苷酸交换因子(GEFs)和 GTP 酶激活蛋白(GAPs)。Rho GTP 酶将上游信号转导至下游效应物,从而调节多种细胞过程,如生长、迁移、黏附和分化。特别是,Rho GTP 酶在调节神经元形态和功能方面起着至关重要的作用。最近的证据表明,Rho GTP 酶信号转导功能障碍在自闭症谱系障碍(ASD)的发病机制中起着重要作用。西蒙斯基金会自闭症研究倡议(SFARI)已发现 20 个编码 Rho GTP 酶调节因子和效应物的基因被列为 ASD 风险基因。本综述总结了这 20 个基因的临床证据、蛋白质结构和蛋白质表达模式。此外,还综述了这些基因的动物模型中的 ASD 相关行为表型,并讨论了在这些动物模型中显示出成功治疗效果的治疗方法。